OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NUF59

Nufarm Ltd

Agricultural ChemicalsVerified

Nufarm's capital structure shows a debt-to-equity ratio of 0.7, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.83, suggesting it can cover its short-term obligations, but its cash and equivalents of AUD 1.26 million are significantly lower than its long-term debt of AUD 1.3 billion, resulting in a negative net cash position. This liquidity profile is assessed as medium risk, with analysts noting the potential for cash flow constraints in the near term. Profitability metrics reveal a challenging operating environment for Nufarm. The company reported a net loss of AUD 186.98 million and an operating loss of AUD 74.00 million in the latest period. Return on equity (ROE) and return on assets (ROA) are negative at -10.03% and -4.12%, respectively, which are below the industry median for Agricultural Chemicals. These figures suggest that Nufarm is underperforming in terms of capital efficiency and asset utilization compared to its peers. Geographically, Nufarm's revenue is concentrated in the Asia-Pacific region, with a significant portion derived from Australia. The company's exposure to this region increases its vulnerability to local economic and regulatory shifts. No specific segment breakdown is available in the provided data, but the lack of diversification in revenue sources could pose a concentration risk. Looking ahead, Nufarm's growth trajectory appears uncertain. The company's free cash flow is negative at AUD -181.71 million, and capital expenditures of AUD -238.36 million indicate ongoing investment in operations. Analysts have issued a mean price target of AUD 3.11, with a median of AUD 2.80, and a mean recommendation of 2.50 (on a 1-5 scale), suggesting a cautious outlook. The company's operating cash flow of AUD 162.77 million provides some buffer, but it is insufficient to cover capital expenditures and debt servicing needs. Risk factors for Nufarm include its negative net income, high debt load, and reliance on a concentrated geographic market. The risk assessment highlights a medium liquidity risk and a low dilution risk, with no immediate pressure from share issuance or dilution. However, the company's negative ROE and ROA suggest a need for operational improvements to restore profitability and investor confidence. Recent events, including the latest financial filing, show a continuation of financial challenges. The company has not issued new debt or equity in the recent period, and there are no notable regulatory or legal developments reported. Analysts have not issued any new guidance or material changes in their outlook since the last reporting period.

30-day price · NUF+0.14 (+6.1%)
Low$2.21High$2.61Close$2.42As of22 May, 00:00 UTC
Profile
CompanyNufarm Ltd
TickerNUF.AX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Nufarm Ltd is an agricultural chemicals company that develops, produces, and distributes crop protection products, including herbicides, insecticides, and fungicides, primarily in Australia and the Asia-Pacific region.

Classification. Nufarm is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry, with a confidence level of 0.92 based on verified market data.

Nufarm's capital structure shows a debt-to-equity ratio of 0.7, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.83, suggesting it can cover its short-term obligations, but its cash and equivalents of AUD 1.26 million are significantly lower than its long-term debt of AUD 1.3 billion, resulting in a negative net cash position. This liquidity profile is assessed as medium risk, with analysts noting the potential for cash flow constraints in the near term. Profitability metrics reveal a challenging operating environment for Nufarm. The company reported a net loss of AUD 186.98 million and an operating loss of AUD 74.00 million in the latest period. Return on equity (ROE) and return on assets (ROA) are negative at -10.03% and -4.12%, respectively, which are below the industry median for Agricultural Chemicals. These figures suggest that Nufarm is underperforming in terms of capital efficiency and asset utilization compared to its peers. Geographically, Nufarm's revenue is concentrated in the Asia-Pacific region, with a significant portion derived from Australia. The company's exposure to this region increases its vulnerability to local economic and regulatory shifts. No specific segment breakdown is available in the provided data, but the lack of diversification in revenue sources could pose a concentration risk. Looking ahead, Nufarm's growth trajectory appears uncertain. The company's free cash flow is negative at AUD -181.71 million, and capital expenditures of AUD -238.36 million indicate ongoing investment in operations. Analysts have issued a mean price target of AUD 3.11, with a median of AUD 2.80, and a mean recommendation of 2.50 (on a 1-5 scale), suggesting a cautious outlook. The company's operating cash flow of AUD 162.77 million provides some buffer, but it is insufficient to cover capital expenditures and debt servicing needs. Risk factors for Nufarm include its negative net income, high debt load, and reliance on a concentrated geographic market. The risk assessment highlights a medium liquidity risk and a low dilution risk, with no immediate pressure from share issuance or dilution. However, the company's negative ROE and ROA suggest a need for operational improvements to restore profitability and investor confidence. Recent events, including the latest financial filing, show a continuation of financial challenges. The company has not issued new debt or equity in the recent period, and there are no notable regulatory or legal developments reported. Analysts have not issued any new guidance or material changes in their outlook since the last reporting period.
Key takeaways
  • Nufarm is experiencing a net loss and negative returns on equity and assets, indicating poor profitability.
  • The company's liquidity position is moderate, with a current ratio of 1.83, but its cash reserves are insufficient to cover long-term debt.
  • Nufarm's geographic concentration in the Asia-Pacific region increases its exposure to regional economic and regulatory risks.
  • Analysts have a cautious outlook, with a mean price target of AUD 3.11 and a median of AUD 2.80.
  • The company's capital expenditures and negative free cash flow suggest ongoing investment in operations, but this is not yet translating into profitability.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue$3.44B
Gross profit$950.1M
Operating income-$74.0M
Net income-$187.0M
R&D
SG&A
D&A
SBC
Operating cash flow$162.8M
CapEx-$238.4M
Free cash flow-$181.7M
Total assets$4.54B
Total liabilities$2.68B
Total equity$1.86B
Cash & equivalents$1.3M
Long-term debt$1.30B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.86B
Net cash-$1.30B
Current ratio1.8
Debt/Equity0.7
ROA-4.1%
ROE-10.0%
Cash conversion-87.0%
CapEx/Revenue-6.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricNUFActivity
Op margin-2.1%5.5% medp25 -0.0% · p75 10.8%bottom quartile
Net margin-5.4%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin27.6%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.9%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity70.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Mean price target3.11 AUD
Median price target2.80 AUD
High price target4.05 AUD
Low price target2.55 AUD
Mean recommendation2.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count4.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.10 AUD
Last actual EPS-0.12 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 11:40 UTC#007fd182
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 19:26 UTCJob: 8d58115b